# Hyaluronic Acid Skin Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/hyaluronic-acid-skin-meta-analysis-evidence-review
Category: evidence-review
Summary: Hyaluronic Acid Skin Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are syst
Last reviewed: 2026-05-27
Reviewed by: Migaku Evidence Review
# Hyaluronic Acid Skin Meta-analysis: What the Evidence Says

## Quick Answer

Hyaluronic Acid Skin Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 2 systematic review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Efficacy and Safety of Amino Acid–Enriched Hyaluronic Acid in Facial Rejuvenation: A Systematic Review and Meta‐Analysis | systematic review | 1 | 2026-02-22 | 10.1111/jocd.70741 |
| Impact of Antioxidant-Rich Whole Foods or Supplements on Skin Health: A Systematic Review and Meta-Analysis of Preclinical and Clinical Studies | systematic review | 1 | 2026-02-27 | 10.3390/antiox15030301 |

## What The Sources Report

- This meta-analysis thus aims to assess the efficacy and safety of injectable HA combined with amino acids for facial rejuvenation in adults, offering an updated, evidence-based overview of their clinical performance. [Mosteirin Maite (2026); evidence level 1]
- Randomized controlled trials were assessed using the Cochrane Collaboration Risk-of-Bias Tool in Review Manager v5.4, which evaluates aspects such as randomization, allocation concealment, blinding, completeness of outcome data, and selective reporting. [Mosteirin Maite (2026); evidence level 1]
- However, these treatments are associated with adverse effects, particularly with prolonged use. [Liang Yuxin (2026); evidence level 1]
- These properties may further improve skin barrier function, support collagen synthesis, increase hydration, and alleviate inflammation-associated skin conditions. [Liang Yuxin (2026); evidence level 1]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For hyaluronic acid skin meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Mosteirin Maite (2026). Efficacy and Safety of Amino Acid–Enriched Hyaluronic Acid in Facial Rejuvenation: A Systematic Review and Meta‐Analysis. DOI: 10.1111/jocd.70741. PMCID: PMC12926521. PMID: 41724989. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12926521/
- Liang Yuxin (2026). Impact of Antioxidant-Rich Whole Foods or Supplements on Skin Health: A Systematic Review and Meta-Analysis of Preclinical and Clinical Studies. DOI: 10.3390/antiox15030301. PMCID: PMC13024200. PMID: 41897448. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13024200/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.